Prothena Corp PLC (PRTA)

CONSUMER STAPLES: RETAIL - FOOD & DRUG
SIC: PHARMACEUTICAL PREPARATIONS

77 SIR JOHN ROGERSON'S QUAY, BLOCK C DUBLIN 2, IRELAND D02 T804

Prothena Corporation plc owns a drug discovery business platform, focused on identifying and translating targets into potential therapies for chronic degenerative and other related disease areas.

Data based on most recent fiscal year report
Market Cap1.51 Billion Shares Outstanding38.45 Million Avg Volume550.757 Thousand
1-Yr BETA vs S&P TR Current Ratio11.41 Quick Ratio11.41
View SEC Filings from PRTA instead.
Q2 2019 All Institutions Hedge Funds 1
To trade PRTA now:
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 129 25 (2.58%)
Aggregate 13F shares on 06/30/2019: 38.599 Million 10.703 Million
Aggregate 13F shares on 03/31/2019: 39.415 Million 8.29 Million
Percent change: -2.07% 29.10%
Funds creating new positions: 25 7
Funds Adding to an existing position: 44 7
Funds closing out their position: 25 8
Funds reducing their position: 26 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PRTA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EKMAN LARS

  • Director
0 2019-09-03 1

ECOR1 CAPITAL, LLC

  • 10% Owner
9,426,640 2019-08-23 1

NOONBERG SARAH B.

  • Director
0 2019-08-08 0

COBB PAULA K

  • Director
0 2019-07-02 2

MALECEK MICHAEL J SEE REMARKS

  • Officer
0 2019-07-01 2

COOKE SHANE

  • Director
82,074 2019-06-12 1

NGUYEN TRAN

  • Director
0 2019-06-11 1

HENNEY CHRISTOPHER S

  • Director
0 2019-05-29 1

SELKOE DENNIS J.

  • Director
4,208 2019-05-22 1

COLLIER RICHARD T

  • Director
1,219 2019-05-22 1

HARFSTRAND KARL ANDERS OLOF

  • Director
0 2019-05-22 1

WALKER KARIN L SEE REMARKS

  • Officer
0 2019-02-27 1

KINNEY GENE G. PRESIDENT AND CEO

  • Officer
  • Director
2,793 2019-02-27 1

KARP CAROL D. CHIEF REGULATORY OFFICER

  • Officer
0 2019-02-27 1

ZAGO WAGNER M. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-02-27 1

TRIPURANENI RADHIKA CHIEF DEVELOPMENT OFFICER

  • Officer
0 2019-02-27 3

HOMAN ARTHUR W CHIEF LEGAL OFFICER

  • Officer
2,000 2018-06-21 0

NICKERSON TARA CHIEF BUSINESS OFFICER

  • Officer
2,000 2018-02-21 0

SCHENK DALE B. PRESIDENT AND CEO

  • Officer
  • Director
14,877 2016-02-24 0

KOLLER MARTIN CHIEF MEDICAL OFFICER

  • Officer
0 2016-02-24 0

MCNINCH DAVID B. CHIEF COMMERCIAL OFFICER

  • Officer
0 2016-02-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments